- Home
- CALC vs GENK Comparison
CALC vs GENK Comparison
Compare CALC & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- GENK
- Stock Information
- Founded
- CALC 2011
- GENK 2011
- Country
- CALC United States
- GENK United States
- Employees
- CALC N/A
- GENK N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- CALC Health Care
- GENK Consumer Discretionary
- Exchange
- CALC Nasdaq
- GENK Nasdaq
- Market Cap
- CALC 22.9M
- GENK 20.4M
- IPO Year
- CALC N/A
- GENK 2023
- Fundamental
- Price
- CALC $2.92
- GENK $3.91
- Analyst Decision
- CALC Strong Buy
- GENK Strong Buy
- Analyst Count
- CALC 2
- GENK 2
- Target Price
- CALC $14.50
- GENK $10.00
- AVG Volume (30 Days)
- CALC 84.0K
- GENK 43.2K
- Earning Date
- CALC 08-11-2025
- GENK 07-30-2025
- Dividend Yield
- CALC N/A
- GENK 0.78%
- EPS Growth
- CALC N/A
- GENK N/A
- EPS
- CALC N/A
- GENK N/A
- Revenue
- CALC N/A
- GENK $214,957,000.00
- Revenue This Year
- CALC N/A
- GENK $17.79
- Revenue Next Year
- CALC N/A
- GENK $15.87
- P/E Ratio
- CALC N/A
- GENK N/A
- Revenue Growth
- CALC N/A
- GENK 14.40
- 52 Week Low
- CALC $1.42
- GENK $3.16
- 52 Week High
- CALC $5.97
- GENK $10.33
- Technical
- Relative Strength Index (RSI)
- CALC 74.28
- GENK 51.36
- Support Level
- CALC $2.00
- GENK $3.74
- Resistance Level
- CALC $2.59
- GENK $4.05
- Average True Range (ATR)
- CALC 0.22
- GENK 0.18
- MACD
- CALC 0.11
- GENK 0.02
- Stochastic Oscillator
- CALC 91.67
- GENK 57.89
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.